Basic Information
Xsome Biotech Inc. is dedicated to developing exosome therapies for a variety of diseases and novel drug delivery vehicles. Currently, XO101, a therapy based on pulmonary spheroid cell-derived exosomes for the treatment of Acute Respiratory Distress Syndrome (ARDS), has received clinical trial approval.
Xsome Biotech Inc.
NorthCarolina,United States of America
unclear
April 16, 2021
--
--
Enterprise Profile
Industrial Sector
Technology
Application Scenarios